KLK4 and hypertensive disorder: Zhao and his colleagues (Zhao et al., 2003) found that a continuous supply of kallikrein (kinin in vivo) can suppress oxidative stress, thus protecting the cardiovascular, renal and central nervous systems against hypertension and associated type 2 diabetes.